25 March 2022: Clinical Research
Retrospective Study of the Etiology, Laboratory Findings, and Management of Patients with Urinary Tract Infections and Urosepsis from a Urology Center in Silesia, Southern Poland Between 2017 and 2020
Zygmunt F. Gofron 1ABCDEFG* , Małgorzata Aptekorz 1CDE , Katarzyna W. Gibas 2BCDEF , Monika Kabała 1DE , Gajane Martirosian 1ABCDEFDOI: 10.12659/MSM.935478
Med Sci Monit 2022; 28:e935478
Table 2 Identical bacterial etiological agents of infections cultured from blood and urine of the same patient.
| Number of strains | |
|---|---|
| Pathogens cultured from urine and blood culture of the same patients (n=80) | 80 |
| ESBL (+)/ ESBL (−) | 26/10 |
| ESBL(+)/ ESBL(−) | 21/6 |
| ESBL (+)/ ESBL (−) | 2/1 |
| Other Gram negative bacteria | 7 |
| HLAR(−)/ HLAR(+) | 3/2 |
| MRSE | 1 |
| MSSA | 1 |
| ESBL – extended-spectrum beta-lactamases; HLAR – high-level aminoglycoside resistance; MRSE – methicillin-resistant ; MRCNS – methicillin-resistant coagulase-negative ; MSSA – methicillin-sensitive ; MSSE – methicillin-sensitive . | |